Patent · US Active

Albumin variants

US8822417B2 · kind B2 · utility

16Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2012
Grant dateSep 2, 2014
Priority date
Expiry dateMay 4, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Variants of a parent albumin having altered plasma half-life compared with a parent albumin are described. Fusion polypeptides and conjugates including the variant albumin are also described. Embodiments include, but are not limited to, a polypeptide which is a variant of albumin, including one or more alterations at one or more positions corresponding to 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119 and 120 in SEQ ID NO: 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.